A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Gold
Gynecologic Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgia Regents University Medical Center
Augusta, Georgia, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Magee-Womens Hospital of Upmc
Pittsburgh, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- Gundersen Lutheran Medical Center
La Crosse, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2009
- Primary completion
- 31 Jul 2012
- Completion
- —
- Last update posted
- 15 Jan 2019
- Registered enrollment
- 31
- Registry id
- NCT00939809
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.